Amisulpride
Who holds supplier records for Amisulpride? 12 organisations hold a current record for Amisulpride: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 12 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5), Italy (3), China (2), France (1) and 1 other country (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Amisulpride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/amisulpride
Reading the evidence
- 12 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 10 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Amisulpride expires 9 Feb 2038. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (12)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Amisulpride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- COSMA SPAItalyCEP Company GMP cert on recordActive DMF 33911 · latest filing Jun 2019
- ICROM SRLItalyCEP Company GMP cert on recordActive DMF 31672, 25523 · latest filing Jul 2017
- IndiaCEP Company GMP cert on record
- IndiaCEP
- ItalyCEP Company GMP cert on record
- Hubei Haosun Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordInactive DMF 23493 · latest filing Jan 2010
- FranceCEP Company GMP cert on record
- IndiaCEP Company GMP cert on record
- IndiaCEP Company GMP cert on record
- IndiaCEP Company GMP cert on record
- ChinaCEP Company GMP cert on record
- Laboratorios Espinos Y Bofill S.A.SpainCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (12)
Certificates of Suitability on the EDQM register for Amisulpride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 16 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| VIYASH SCIENTIFIC LIMITED Hyderabad | IN | CEP 2024-222 - Rev 02 Amisulpride, Process-2, ASP | Jul 2026 | — |
| ICROM S.R.L. Concorezzo | IT | CEP 2019-051 - Rev 05 Amisulpride, Process 2 | Mar 2026 | Inspected Feb 2025 Italy |
| SANOFI WINTHROP INDUSTRIE Gentilly | FR | CEP 2002-208 - Rev 11 Amisulpride | Jun 2025 | — |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai | IN | CEP 2016-028 - Rev 01 Amisulpride, Process II | Jan 2025 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2010-005 - Rev 05 Amisulpride | Sept 2024 | — |
| CTX LIFESCIENCES PVT. LIMITED Surat | IN | R0-CEP 2022-167 - Rev 00 Amisulpride | Aug 2023 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai | CN | R0-CEP 2021-464 - Rev 00 Amisulpride | Jun 2023 | — |
| HUBEI HAOSUN PHARMACEUTICAL CO., LTD. Ezhou | CN | R1-CEP 2009-342 - Rev 03 Amisulpride | Jan 2020 | — |
| Laboratorios Espinos Y Bofill S.A. (LEBSA) Cornellà | ES | R1-CEP 2003-099 - Rev 03 Amisulpride | Sept 2019 | — |
| SYMED LABS LIMITED Hyderabad | IN | R1-CEP 2010-185 - Rev 01 Amisulpride | Feb 2019 | — |
| ERREGIERRE S.P.A. San Paolo D'Argon | IT | R1-CEP 2008-202 - Rev 03 Amisulpride | Dec 2017 | — |
| Cosma S.p.A. Ciserano | IT | R1-CEP 2009-397 - Rev 01 Amisulpride | Aug 2017 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (1)
Organisations whose Type II DMFs for Amisulpride are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- SYLACHIMInactive DMF 12737 · filed Nov 1997
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (2 listed products contain Amisulpride). The latest listed patent expires 9 Feb 2038. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Amisulpride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL243712).
Chemical identity
- IUPAC name
- 4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxybenzamide
- Canonical SMILES
- CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC
- InChIKey
- NTJOBXMMWNYJFB-UHFFFAOYSA-N
- Synonyms
- Aminosultopride, Amisulprida, Amisulpride, APD-421, APD421, Barhemsys, DAN-2163, Deniban, NSC-760085, Socian, Solian, Solian 100
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Dopamine-2 Receptor Antagonist
- Mechanism of action
- Dopamine D2 Antagonists
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Amisulpride?
12 organisations hold an active US FDA Type II Drug Master File or a CEP for Amisulpride: COSMA SPA (Italy), ICROM SRL (Italy), APITORIA PHARMA PRIVATE LTD (India), Ctx Lifesciences (India), ERREGIERRE SPA (Italy), Hubei Haosun Pharmaceutical Co., Ltd. (China), Sanofi Winthrop Industrie (France) and Sun Pharmaceutical Industries Limited (India), and 4 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Amisulpride Drug Master Files are active?
COSMA SPA (DMF 33911) and ICROM SRL (DMF 31672, 25523). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Amisulpride records mean?
1 organisation has only inactive Type II DMFs for Amisulpride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Amisulpride have a European Certificate of Suitability?
Yes. 12 organisations hold a valid CEP for Amisulpride on the EDQM register, including VIYASH SCIENTIFIC LIMITED Hyderabad (IN), ICROM S.R.L. Concorezzo (IT), SANOFI WINTHROP INDUSTRIE Gentilly (FR), SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and CTX LIFESCIENCES PVT. LIMITED Surat (IN) and 6 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Amisulpride?
Yes. The latest patent listed for an approved US product containing Amisulpride expires 9 Feb 2038, across 2 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Amisulpride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Amisulpride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.